COMPUTED DESCRIPTORS
| Molecular Weight | 1726.2 g/mol |
|---|---|
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 42 |
| Rotatable Bond Count | 15 |
| Exact Mass | 1725.7319164 g/mol |
| Monoisotopic Mass | 1725.7319164 g/mol |
| Topological Polar Surface Area | 810 Ų |
| Heavy Atom Count | 97 |
| Formal Charge | 0 |
| Complexity | 337 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 22 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Zoledronate Trisodium is the trisodium salt form of zoledronate, a synthetic imidazole, third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate (diphosphate) synthase, thereby preventing protein prenylation within the mevalonate pathway. This leads to the loss of downstream metabolites essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, zoledronate decreases bone turnover and stabilizes the bone matrix.